Issue #6
-
Friday General Session features late-breaking data from KATHERINE and INAVO120 clinical trials
Findings from 11 studies were presented Friday during the third and final General Session of the 2023 SABCS®.
-
AACR Outstanding Investigator outlines need for better metastatic breast cancer models
Alana L. Welm, PhD, on Friday discussed what she was doing to model metastatic breast tumors using patient-derived xenografts and organoids, and she implored her fellow researchers to work together to advance the field.
-
Panelists explore challenging, unresolved breast cancer questions based on real-world case studies
Audience members brought real-world clinical cases and concerns before a multidisciplinary panel on Thursday, prompting discussions about choosing optimal care and treatment for patients with breast cancer in routine practice.